Status:

COMPLETED

Bone Substitute in the Multi Traumatized Nasal Septum Reconstruction

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Nasal Septum

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

The aim of this project is to evaluate the safety and efficacy of the biomaterial made of HAP/TCP (BCP, Kasios®), in septoplasties of multi traumatized human nose. The use of this biomaterial will avo...

Detailed Description

Five to ten percent of the post-traumatic septo-rhinoplasties require a total reconstruction of the septal skeleton. This surgery requires using autologous bone graft (iliac, costal, or parietal). How...

Eligibility Criteria

Inclusion

  • Men and women between 18 and 60
  • Indication of tissue replacement in a nasal septum, which skeleton is lacking or non usable for patients having:
  • Paradoxal nasal obstruction with saddle nose type III and IV or flabby nose
  • Nasal obstruction with an obstacle caused by a moved multifracture skeleton
  • Written informed consent
  • Patient with social insurance

Exclusion

  • Post-menopausal women : lack of efficient contraception (intra uterine dispositive or contraceptive pill)
  • Breast feeding or pregnant women
  • HIV or VHB or VHC seropositive subject
  • Inflammatory or infectious active rhino sinusitis
  • Nasal an sinus surgery or trauma ended from less than 8 months
  • Toxic medicated Rhinitis to vasoconstrictors
  • Diabetic : all type of diabetes (without or with therapy)
  • Non treated cardiac disease
  • Any contra indication to surgery
  • Any contra indication to the biomaterial use like evolutive infection, bone disease or local necrosis
  • Radiotherapy antecedent of the cephalic and cervical extremity
  • Local or regional therapy with corticoids currently, or stopped from less than 2 months
  • Patient participating to another study with an exclusion period still going on during pre-inclusion period

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2014

Estimated Enrollment :

26 Patients enrolled

Trial Details

Trial ID

NCT01234415

Start Date

September 1 2011

End Date

November 1 2014

Last Update

March 18 2015

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Service d'Oto-rhino-laryngologie et Chirurgie cervico-faciale - CHU de Bordeaux

Bordeaux, France, 330176

2

Service d'Oto-rhino-laryngologie - Clinique St Augustin

Bordeaux, France, 33074

3

Service d'Oto-rhino-laryngologie - Hôpital Dupuytren

Limoges, France, 87042